CMCM
Cheetah Mobile Inc.
CMCM lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to hold roughly steady.
NBIS
Nebius Group N.V.
There isn't enough reported data to score NBIS yet.
CMCM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Strong |
CMCM's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
NBIS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Healthy |
NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
CMCM PE Valuation
CMCM has no meaningful PE right now: it lost money over the past year.
NBIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 68x | $22.45 | -83% |
| Fair | 114x | $37.67 | -71% |
| Current | 390x | $129 | — |
| Expensive | 666x | $220 | +71% |
Historical ranges are pointers, not guarantees.
NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.
CMCM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect CMCM's earnings, revenue and profitability to hold roughly steady.
NBIS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
NBIS has the edge over CMCM on the outlook, with more favorable revenue and profitability expectations.
CMCM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$76.24 | +$41.87 |
| Q1 2026 | -$59.05 | +$84.04 |
| Q4 2025 | -$63.18 | +$91.17 |
| Q3 2025 | -$109.10 | -$5.40 |
| Q2 2025 | -$118.11 | +$14.85 |
| Q1 2025 | -$143.09 | -$5.32 |
| Q4 2024 | -$154.35 | -$0.83 |
| Q3 2024 | -$103.70 | +$67.16 |
CMCM is still losing money, but far less than before: $76.24 per share over the past year, against $188.19 at its worst in mid-2023.
NBIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.33 | +$2.61 |
| Q4 2024 | -$2.28 | -456% |
| Q4 2023 | $0.64 | -36% |
| Q4 2022 | $1.00 | +$1.49 |
| Q4 2021 | -$0.49 | -156% |
| Q4 2020 | $0.87 | +89% |
| Q4 2019 | $0.46 | -73% |
| Q4 2018 | $1.71 | +434% |
NBIS has the edge over CMCM in the latest year-over-year earnings comparison.
CMCM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $39.9M | -9.9% |
| Q1 2026 | $38.9M | 0% |
| Q4 2025 | $46.3M | +30% |
| Q3 2025 | $43.1M | +50% |
| Q2 2025 | $44.3M | +58% |
| Q1 2025 | $38.9M | +36% |
| Q4 2024 | $35.6M | +42% |
| Q3 2024 | $28.8M | +17% |
CMCM has the edge over NBIS in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -13% | -8.9 points |
| Q1 2026 | -11% | -0.7 points |
| Q4 2025 | -34% | -11 points |
| Q3 2025 | 1.4% | +39 points |
| Q2 2025 | -3.8% | +38 points |
| Q1 2025 | -10% | +32 points |
| Q4 2024 | -23% | +14 points |
| Q3 2024 | -37% | -13 points |
CMCM's operating margin was −13% last quarter, down 8.9 points from the same quarter a year ago.
NBIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2023 | $9.7B | +53% |
| Q4 2022 | $6.3B | +46% |
| Q4 2021 | $4.3B | +63% |
| Q4 2020 | $2.6B | +24% |
| Q4 2019 | $2.1B | +37% |
| Q4 2018 | $1.5B | +36% |
| Q4 2017 | $1.1B | +24% |
| Q4 2016 | $917M | +27% |
NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -115% | -112 points |
| Q4 2023 | 3.6% | -11 points |
| Q4 2022 | 2.5% | -14 points |
| Q4 2021 | -3.7% | -18 points |
| Q4 2020 | 7.4% | -9.5 points |
| Q4 2019 | 14% | -2 points |
| Q4 2018 | 16% | -14 points |
| Q4 2017 | 14% | -19 points |
NBIS's operating margin was −115% last quarter, down 123 points from the same quarter a year ago, near the bottom of its range since 2011.
CMCM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | -$27.8M | -$27.8M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
CMCM's free cash flow was −$28M over the past year, against $0 the year before.
NBIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$3.7B | -$3.1B |
| Q4 2024 | -$562.1M | -$316.2M |
| Q4 2023 | -$245.9M | -$138.9M |
| Q4 2022 | -$107M | +$319.7M |
| Q4 2021 | -$426.7M | -539% |
| Q4 2020 | $97.3M | -66% |
| Q4 2019 | $287.9M | +$289.2M |
| Q4 2018 | -$1.3M | -101% |
NBIS has burned cash in six of the last eight quarters: −$4.6B over the past year, against −$43M the year before.
CMCM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +765 shares |
| 1 year | +2.3% | +14.2K shares |
| 3 years | +7% | +40.7K shares |
| 5 years | +8.3% | +47.9K shares |
| Available history | +13% | +71.1K shares |
CMCM has 621,551 diluted shares, up 2.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
CMCM hasn't bought back shares in the past year.
NBIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -12% | -33.3M shares |
| 1 year | -32% | -115M shares |
| 3 years | -26% | -86.9M shares |
NBIS has the edge over CMCM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | $10M |
| Q4 2021 | $84.1M |
| Q4 2020 | $122.8M |
| Q4 2019 | $17.2M |
| Q4 2018 | $121.8M |
| Q4 2014 | $101.7M |
| Q4 2013 | $102.9M |
CMCM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -168.5x | Net Cash |
| Q4 2025 | -159.4x | Net Cash |
CMCM has more cash than debt.
NBIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 0.7x | Very low |
| Q4 2022 | -0.7x | Net Cash |
NBIS's net debt is less than a year of its operating earnings (EBITDA).
CMCM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.9 | Oversold |
| Stochastic | 18.7 | Oversold |
CMCM's weekly RSI is 30 (oversold) and its Stochastic is 19 (oversold).
NBIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 8.3 | Oversold |
NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
CMCM PE vs Communication Services Sector
CMCM has no meaningful PE right now: it lost money over the past year.
NBIS PE vs Communication Services Sector
| Metric | NBIS | Sector median | Relative |
|---|---|---|---|
| PE | 390x | 16x | 2,264% above |
| PE % | 62 | 24 | 38 pts above |
NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.
CMCM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.44 | 7.8% below |
| 20 week MA | $2.83 | 20% below |
| 50 week MA | $4.57 | 51% below |
| 100 week MA | $4.99 | 55% below |
| 200 week MA | $4.01 | 44% below |
NBIS has stronger trend alignment. CMCM is above 0 of 5 weekly averages versus NBIS above 1 of 4.
NBIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $179.7 | 28% below |
| 20 week MA | $199.9 | 36% below |
| 50 week MA | $163.5 | 21% below |
| 100 week MA | $110.0 | 17% above |
NBIS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 17% above its 100-week average.
CMCM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.7 | $9.65 | -45% |
| 2021 | $9.65 | $6.20 | -36% |
| 2022 | $6.20 | $1.91 | -69% |
| 2023 | $1.91 | $2.28 | +19% |
| 2024 | $2.28 | $4.90 | +115% |
| 2025 | $4.90 | $6.34 | +29% |
| 2026 YTD | $6.34 | $2.25 | -65% |
CMCM's yearly returns have swung widely, from +115% in 2024 to −69% in 2022. It's down 65% so far in 2026.
NBIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $19.6 | $27.3 | +40% |
| 2025 | $27.3 | $87.6 | +221% |
| 2026 YTD | $87.6 | $128.6 | +47% |
NBIS has the edge over CMCM on returns for 2026, with the stronger performance.